EUVIMEDEUVIMED entdecken
Crossref

Prevalence of Molecular Subtypes of Gastric Cancer in Taiwan and the Impact of High SLC25A22 Expression on Survival: A Single‐Center Experience

Yu-Ting Lee, Shu-Hui Lin, Kun-Tu Yeh, Kit-San Yu, Po-Yen Hsu, Michael W Y Chan

Molecular Carcinogenesis · 2026-06 · 65 (6) · 770-776

DOI: 10.1002/mc.70111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, online erschienen am 23.03.2026. Verfasst von Yu-Ting Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Division of Hematology and Oncology, Chiayi, Taiwan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Adenocarcinoma, Mitochondrial Membrane Transport Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SLC25A22 is a mitochondrial inner membrane glutamate transporter responsible for shuttling glutamate from the cytoplasm into the mitochondrial matrix. Its clinical significance in gastric cancer (GC) remains unclear. GC can be classified into four molecular subtypes: Epstein‐Barr virus (EBV)‐associated, microsatellite instability (MSI), genomic stability (GS), and chromosomal instability (CIN). In this study, we evaluated the distribution of GC molecular subtypes in Taiwan and examined the association between SLC25A22 expression and patient outcomes. A total of 235 patients with gastric adenocarcinoma treated at Changhua Christian Hospital were included. Tumor subtypes were determined using immunohistochemistry and Epstein‐Barr encoding region (EBER) in situ hybridization according to established criteria, and SLC25A22 expression was assessed using an immunohistochemical scoring system. The prevalence of EBV‐associated tumors, MMR deficiency (MSI subtype), CIN, and other subtypes was 8.1%, 6.8%, 70.2%, and 14.9%, respectively. EBV‐associated tumors showed a relatively lower incidence of metastatic disease ( p = 0.014). The median SLC25A22 expression scores were 85 in EBV‐associated tumors, 90 in MMR‐deficient tumors, 90 in CIN tumors, and 100 in other subtypes. Higher SLC25A22 expression (score > 90) was associated with poorer prognosis ( p = 0.014). Our findings indicate that the MSI subtype of GC has a relatively low prevalence in Taiwan and suggest that elevated SLC25A22 expression may serve as a potential biomarker associated with unfavorable prognosis in gastric cancer. Further studies are needed to clarify the biological role of SLC25A22 in tumor progression and therapeutic resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAdenocarcinomaMitochondrial Membrane Transport ProteinsHumansMaleTaiwanFemaleMicrosatellite InstabilityMiddle AgedAgedPrognosisEpstein-Barr Virus InfectionsAdultBiomarkers, TumorHerpesvirus 4, HumanPrevalenceAged, 80 and overChromosomal Instability

Stichwörter der Autor:innen

Epstein–Barr virus (EBV)SLC25A22chromosomal instability (CIN)gastric cancergenomic stability (GS)microsatellite instability (MSI)

Substanzen

Mitochondrial Membrane Transport ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Division of Hematology and Oncology, Chiayi, Taiwan.
  • Department of Biomedical Sciences, National Chung Cheng University, Min-Hsiung, Chiayi, Taiwan.
  • Epigenomics and Human Disease Research Center, National Chung Cheng University, Min-Hsiung, Chiayi, Taiwan.
  • Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
  • Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan.

Zitieren

APA

Lee, Y. T., Lin, S. H., Yeh, K. T., Yu, K. S., Hsu, P. Y., & Chan, M. W. Y. (2026). Prevalence of Molecular Subtypes of Gastric Cancer in Taiwan and the Impact of High SLC25A22 Expression on Survival: A Single‐Center Experience. Molecular Carcinogenesis, 65(6), 770-776. https://doi.org/10.1002/mc.70111

Vancouver

Lee YT, Lin SH, Yeh KT, Yu KS, Hsu PY, Chan MWY. Prevalence of Molecular Subtypes of Gastric Cancer in Taiwan and the Impact of High SLC25A22 Expression on Survival: A Single‐Center Experience. Molecular Carcinogenesis. 2026;65(6):770-776. doi:10.1002/mc.70111

BibTeX
@article{Lee2026,
  author = {Lee, Yu-Ting and Lin, Shu-Hui and Yeh, Kun-Tu and Yu, Kit-San and Hsu, Po-Yen and Chan, Michael W Y},
  title = {Prevalence of Molecular Subtypes of Gastric Cancer in Taiwan and the Impact of High SLC25A22 Expression on Survival: A Single‐Center Experience},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  volume = {65},
  number = {6},
  pages = {770--776},
  doi = {10.1002/mc.70111}
}
Kostenlos starten →